I
319.56
0.79 (0.25%)
| Penutupan Terdahulu | 318.77 |
| Buka | 319.48 |
| Jumlah Dagangan | 151,428 |
| Purata Dagangan (3B) | 612,242 |
| Modal Pasaran | 22,494,638,080 |
| Harga / Pendapatan (P/E TTM) | 97.43 |
| Harga / Pendapatan (P/E Ke hadapan) | 54.95 |
| Harga / Jualan (P/S) | 8.78 |
| Harga / Buku (P/B) | 15.47 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | 18.29% |
| Margin Operasi (TTM) | 15.61% |
| EPS Cair (TTM) | 5.54 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 28.80% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -31.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 131.40% |
| Nisbah Semasa (MRQ) | 4.47 |
| Aliran Tunai Operasi (OCF TTM) | 406.50 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 84.25 M |
| Pulangan Atas Aset (ROA TTM) | 6.94% |
| Pulangan Atas Ekuiti (ROE TTM) | 37.92% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Insulet Corporation | Menaik | Menaik |
AISkor Stockmoo
1.0
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -0.5 |
| Purata | 1.00 |
|
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 0.29% |
| % Dimiliki oleh Institusi | 102.56% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 432.00 (Canaccord Genuity, 35.19%) | Beli |
| Median | 380.00 (18.91%) | |
| Rendah | 316.00 (Barclays, -1.11%) | Pegang |
| Purata | 381.50 (19.38%) | |
| Jumlah | 9 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 331.90 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Canaccord Genuity | 24 Nov 2025 | 432.00 (35.19%) | Beli | 337.53 |
| 07 Nov 2025 | 428.00 (33.93%) | Beli | 319.82 | |
| BTIG | 21 Nov 2025 | 380.00 (18.91%) | Beli | 331.17 |
| 13 Nov 2025 | 370.00 (15.78%) | Beli | 332.67 | |
| RBC Capital | 21 Nov 2025 | 380.00 (18.91%) | Beli | 331.17 |
| 07 Nov 2025 | 370.00 (15.78%) | Beli | 319.82 | |
| Truist Securities | 21 Nov 2025 | 412.00 (28.93%) | Beli | 331.17 |
| 07 Nov 2025 | 390.00 (22.04%) | Beli | 319.82 | |
| UBS | 19 Nov 2025 | 400.00 (25.17%) | Beli | 346.36 |
| 07 Nov 2025 | 355.00 (11.09%) | Pegang | 319.82 | |
| Barclays | 07 Nov 2025 | 316.00 (-1.11%) | Pegang | 319.82 |
| 05 Nov 2025 | 301.00 (-5.81%) | Pegang | 314.44 | |
| Wells Fargo | 07 Nov 2025 | 360.00 (12.65%) | Beli | 319.82 |
| Jefferies | 06 Nov 2025 | 400.00 (25.17%) | Beli | 323.40 |
| Stifel | 21 Oct 2025 | 370.00 (15.78%) | Beli | 328.97 |
| Oppenheimer | 08 Sep 2025 | 365.00 (14.22%) | Beli | 349.56 |
| Papar semua | ||||
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 04 Dec 2025 | Pengumuman | Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience |
| 20 Nov 2025 | Pengumuman | Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day |
| 06 Nov 2025 | Pengumuman | Insulet Reports Third Quarter 2025 Results |
| 30 Oct 2025 | Pengumuman | Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month |
| 23 Oct 2025 | Pengumuman | Insulet Announces Appointment of Robert L. Huffines to its Board of Directors |
| 10 Oct 2025 | Pengumuman | Insulet to Host Investor Day on November 20, 2025 |
| 18 Sep 2025 | Pengumuman | Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette |
| 16 Sep 2025 | Pengumuman | Insulet Announces CFO Transition |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |